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Social Media:  24 
Statement: Female runners with low hip bone mineral density, menstrual changes during peak 25 
training, and elevated bone turnover markers may be at increased risk of stress fracture, and thus 26 























Background: Female runners are at increased risk of stress fractures (SF) compared to men. 48 
Literature is lacking in regard to best practice for preventing and treating SF in women. The 49 
purpose of the study was to compare physiological measures and running related factors between 50 
women with and without running-related SF histories of various ages and running abilities. 51 
Hypothesis: Women with and without SF histories would differ in medical and menstrual 52 
history, bone health, body composition, nutrition, and running history. 53 
Study Design: Prospective cohort study 54 
Level of Evidence: 2b 55 
Methods: Twenty female runners with SF histories were age and running-distance matched with 56 
20 women without SF histories. Data included medical, menstrual, running, injury, and 57 
nutritional histories; blood histology related to nutritional, hormonal, and bone-related risk 58 
factors; and bone density, fat, and lean tissue using Dual Energy X-ray Absorptiometry. Paired t-59 
tests were used to examine differences between women with and without SF histories, and 60 
Spearmen correlations were conducted to examine relationships between physiological factors.  61 
Results: Women with SF histories had lower hip bone mineral density compared to women 62 
without SF histories (p<0.05). SF history was moderately correlated with menstrual changes 63 
during increased training times (r=0.580, p <.0001) but was not correlated with any other 64 
physiological factor. There was a moderate correlation within the SF group (r=0.65, p=.004) for 65 
bone markers for resorption and formation both increasing, indicating increased bone turnover. 66 
Conclusion: Female runners with low hip bone mineral density, menstrual changes during peak 67 
training, and elevated bone turnover markers may be at increased risk of SF.  68 
4 
 
Clinical Relevance: Female runners need routine screening for risks associated with SF 69 
occurrence. As bone mineral density and bone turnover markers are not routinely assessed in this 70 
population, important risk factors may be missed. 71 
 72 






















Stress fractures (SFs) are non-traumatic incomplete fractures resulting from repetitive loading on 93 
normal bone or from normal loading on abnormal bone.11 Running related SFs account for 69% 94 
of all SFs with 95% occurring in the lower extremities and pelvis.11 Women have at least 2 times 95 
greater risk than men,13,16 and more women than men are now running. In the 2018 National 96 
Runner Survey, runners were 54% female, 52% of all runners were between ages 35 and 54, and 97 
60% considered themselves frequent fitness runners.29 98 
 99 
The risk factors for SFs in women are multifactorial, and include differences in anatomy, body 100 
composition, metabolism, the cardiovascular system, hormonal status, and psychological status 101 
as compared to men.16 Both intrinsic and extrinsic factors contribute to the occurrence of SFs. 102 
Intrinsic factors are physiological11 and include bone structure and density, decreased fat in 103 
relation to lean tissue, and nutritional, hormonal, and bone-related health status. Menstrual 104 
irregularities and energy deficiency due to an imbalance between nutritional intake and activity 105 
are often present.22 Women also have greater risks due to the female athlete triad, a negative 106 
energy balance between nutritional intake and activity that can lead to menstrual issues and 107 
decreased bone mineral density, showing the inter-relationships of these factors.20 Both pre-108 
menopausal and post-menopausal women are at risk.20,26 Extrinsic factors include training 109 
intensity, training surfaces, diet, and footwear.11  110 
 111 
The literature is lacking in regard to best practice for preventing and treating SFs in women. 112 
Surprisingly, few studies4,27 directly evaluate women with and without a history of SFs to assist 113 
in better assessing risk and developing preventative strategies. There are several articles related 114 
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to risk factors,11,13,16,20,23 a few case reports with female runners,3,10,12,18 and a few observational15 115 
and experimental studies.4,21,27,30 These studies examine various factors including bone density, 116 
nutritional status, biomechanics, and menstrual status. Overall these studies show some 117 
relationships between these factors. Some limitations include small sample sizes in most studies, 118 
inclusion of only high level adolescent or young female runners, and mixed populations 119 
(male/female or different sports). Due to these limitations and the increased SF for women, there 120 
is a significant need to better understand issues related to SFs to prevent and properly treat these 121 
injuries to optimize return to running, overall health, and participation. The issue is not limited to 122 
women of a specific age as hormonal issues affect all women runners, thus making it important 123 
to not limit studies to young elite runners. Therefore, the objective of this study is to compare 124 
important physiological measures between women with and without running-related SF histories 125 
of various ages and running abilities. The hypothesis was that there would be differences related 126 
to medical and menstrual history, bone health, body composition, nutrition, and running history. 127 
 128 
METHODS 129 
Female runners, age 18-65 years, with and without running-related SF histories were recruited 130 
over a 5 month time period via posted flyers and social media for this study held within an urban 131 
university hospital system. A variety of social media sites were identified to decrease possible 132 
selection bias. Women self-identified as runners, with no upper or lower limit set for running 133 
intensity, duration, or distance. To control for differences in age and running ability, after each 134 
woman with a SF history was enrolled into the study, a woman without a SF history was 135 
recruited who was age-matched within 5 years and running-distance-matched within 10 136 
miles/week.5,31 All enrolled women signed a written informed consent form approved by the 137 
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governing Institutional Review Board. Women with SF were included if they had a SF at any 138 
time as runners. Women with and without SF histories were excluded if they had a neurologic 139 
diagnosis or any systemic medical condition that would impact bone, were pregnant, or were 140 
breastfeeding. 141 
 142 
Data collection included background information and physiological measures. Participants 143 
completed an online questionnaire (Qualtrics, Seattle, WA) to collect demographics as well as 144 
medical, menstrual, running, injury, and nutritional histories. To examine physiological data on 145 
nutritional, hormonal, and bone related risk factors,8 the following non-fasting serum histological 146 
measures were collected and processed using standard medical laboratory procedures: complete 147 
blood count, vitamin D (25-(OH)D), calcium, albumin, parathyroid hormone, estradiol, 148 
testosterone, bone specific alkaline phosphatase (BALP, measure of bone formation),6 and N-149 
telopeptide (N-Tx, measure of bone resorption).6 To examine bone, fat, and lean tissue, Dual 150 
Energy X-ray Absorptiometry (DXA)9 was used to measure areal bone mineral density (aBMD) 151 
of the left hip and the lumbar spine, and full body composition using a Hologic Horizon A 152 
scanner (Hologic, Marlborough, MA). The DXA machine was calibrated prior to each testing 153 
session to decrease measurement error. A negative pregnancy test was required prior to 154 
conducting the DXA for all participants. 155 
 156 
To examine differences between women with and without SF histories, paired t-tests were 157 
conducted using SPSS Statistics Version 25 (IBM Corporation, Armonk, New York). Cohen’s d 158 
was calculated to determine effect size. To examine possible relationships between group and 159 
physiological factors and among different physiological factors, Spearmen correlations were 160 
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performed. Due to the lack of data available on medical and menstrual history, bone health, body 161 
composition, nutrition, and running history that span the age ranges included, a sample of 20 per 162 
group was chosen based on differences in bone turnover, body mass, and estradiol levels seen in 163 
study with 37 adolescent runners.2 Effect sizes were thus calculated for measures in this study. 164 
  165 
RESULTS 166 
Forty nine women were screened for the study. Two women with SF histories were excluded due 167 
to thyroid disease, and five eligible women without SF histories were excluded as they did not 168 
match with a woman with a SF. Forty two women (35.0 ± 7.4, range 22-50 years) enrolled into 169 
the study. Two participants withdrew after signing the consent form due to time constraints, and 170 
data are complete for 40 participants or 20 matched pairs. Data were complete for all participants 171 
expect for 1 missing albumin value for the SF group and 2 missing N-Tx values for the non-SF 172 
group. These data and the matched pair’s values were thus excluded from data analysis.  173 
 174 
The oldest enrolled woman was 50 years old, and she was the only participant who was post-175 
menopausal. Her match with a SF history was peri-menopausal. Women were highly educated 176 
and predominately white (Table 1). Women with SF histories were 2.2 ± 2.6 years post their 177 
most recent fracture (range 0.8-10 years) with 10 having fractured within the past year, 5 in the 178 
last 1-3 years, and 5 more than 5 years prior.  Fracture sites included tibia (n=15), metatarsal 179 
(n=8), femur (n=5), cuneiform (n=1), and sesamoid (n=1) with 6 participants reporting having 180 




Tables 2 and 3 show self-reported information for running and menstrual status, respectively, 183 
and there were no differences (p=0.57-1.00) between groups for these data. Groups were also 184 
evenly distributed in regard to birth control use and type, and for the number who had ever gone 185 
>3 months without a period other than during pregnancy (6 per group). However, 12 women who 186 
had a SF reported that their menstrual periods changed during increased training times, while 187 
only 1 reported this occurring in the non-SF group. Age when started running did not differ 188 
between groups, yet 9 women with SF histories started running at 18 years or younger, while 189 
only 4 without SF started this young.  190 
 191 
In comparing physiological measures between women with and without SF histories (Table 4), 192 
the only statistical difference was in hip aBMD, with lower aBMD in the women with a SF 193 
history. But the effect size for this difference was low (0.19). The measure with the largest effect 194 
size of 0.61 was BALP, but the difference between groups was not statically significant. 195 
Correlational analysis showed that time post fracture was unrelated to bone markers (BALP, N-196 
Tx) and that hip aBMD was unrelated to any other physiological factor. SF history was 197 
moderately correlated with menstrual changes during increased training times (r=0.580, p 198 
<.0001) but was not correlated with any other physiological factor. While there was a low 199 
correlation between BALP and N-Tx when looking at all participants together (r=0.34, p=.03), 200 
there was a moderate correlation within the SF group (r=0.65, p=.004) with BALP and N-Tx 201 







The main results from this study were that women with a SF history had lower hip aBMD than 207 
their matched counterparts without a SF history, and that women with a SF history had 208 
alterations in their typical menstrual cycles during more intense training times even though 209 
current estradiol levels did not differ between groups. The study was conducted during the 210 
months of March to June, which represented mainly off to early season training for the included 211 
women. Within the SF group, there was a correlation between bone formation and resorption that 212 
was not seen within the non-SF group, indicating increased bone turnover.17 Of note, DXA for 213 
bone density and blood histology to examine bone resorption and formation markers are not 214 
routinely performed in this population, thus important information may be missed clinically in 215 
these women. As DXA is a relatively inexpensive with low radiation exposure, performing DXA 216 
in this population may be cost-effective.  The more expensive tests for bone resorption and 217 
formation markers may then be performed based on concerning findings via DXA. Asking 218 
female runners about any menstrual cycle changes during heavier training times may be an 219 
important addition to a patient interview. Women who had these changes reported lighter flow, 220 
shorter duration, increased spotting, irregularity, and missed cycles. 221 
 222 
Several studies have examined menstrual dysfunction in relation to bone, but primarily in a 223 
younger population. Ackerman et al.1 reported decreased spine and whole body aBMD and 224 
altered bone structure in 14-25 year old female athletes with oligoamenorrhea (6 cycles or less in 225 
prior year), with greater changes seen in participants with more than 1 SF. In a study that 226 
included collegiate cross-country runners, Tenforde et al.30 reported that oligoamenorrhea or 227 
amenorrhea and a prior SF were predictors of subsequent bone stress injuries. A small 228 
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percentage of participants had low aBMD, with more than half of them being runners. Nose-229 
Ogura et al.24 found a relationship between amenorrhea in the teenage years and aBMD in the 230 
20’s for female athletes that included distance runners, suggesting the need for intervention at a 231 
younger age.  While these studies provide important information for female runners in these 232 
younger age groups, women older than 25 years represent a large number of runners. As bone 233 
mass starts to decline between 20 and 30 years of age for women,7 issues specific to these 234 
women must also be addressed. Micklesfield et al.22 studied 613 long distance (half-marathon 235 
and ultramarathon) female runners ages 16-62 years, of whom 17.3% had sustained a bone stress 236 
injury, but found no differences between these women and the women without these injuries for 237 
age, weight, BMI, or menstrual function. They also found that over half of all 613 women 238 
reported menstrual dysfunction. Thus, further study is needed to better understand the risks. 239 
These studies that relate menstrual status and aBMD as well as the results of this current study 240 
indicate the need to evaluate and treat female runners for these issues early and to continue to 241 
evaluate changes over time. 242 
 243 
While there were no differences in estrogen levels between women with and without SF 244 
histories, some women in the study had very low estrogen levels. The low end of the normal 245 
range for estrogen levels is 24 pg/mL. Four women with SF histories and eight without had very 246 
low values (<5 pg/mL), and two in each group had low values (8-23 pg/mL). The significance of 247 
these low values is difficult to determine in this small sample as the women with and without SF 248 
histories were equally impacted. Estrogen levels fluctuate during the menstrual cycle,28 and data 249 
were not collected regarding menstrual phase in this study. To gather cyclical data on female 250 
runners would require measures of estrogen levels to be collected throughout the menstrual cycle 251 
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to identify patterns.28 Assessing estrogen levels across the menstrual cycle is thus recommended 252 
for future studies. 253 
 254 
The bone turnover markers of N-Tx and BALP as measured in this study are not routinely 255 
assessed in female runners but may play a role in assessing risk. While these measures were not 256 
statistically significant different between groups in this study, there was a correlation between 257 
increased bone formation and resorption in the SF group, indicating increased bone turnover.17 In 258 
a literature review of studies of post-menopausal women by Vasikaran et al.,32 several studies 259 
reported that an increase in bone turnover markers led to an additive effect on the risk for 260 
fractures, and that increased bone turnover markers may predict fracture risk independently of 261 
aBMD. While the population in Vasikaran et al.32 differs from the women runners in this study, 262 
the use of these markers may be beneficial and more research is warranted. In a sample of 263 
adolescent female cross-country runners, elevated bone markers were associated with a lower 264 
BMI, menstrual irregularities, and lower estradiol and Vitamin D levels.2 In contrast, Fujita et 265 
al.14 measured bone resorption (urine N-Tx) twice per year in a small sample of female runners 266 
ages 19-34, and found while N-Tx values were normal during training, they increased when a SF 267 
occurred. These findings suggest that N-Tx may be a non-invasive way to identify SFs and 268 
monitor healing. A review article by Papageorgiou et al.25 reported that short term low energy 269 
availability can also elevate bone markers, thus several factors need to be considered when using 270 
bone markers to guide diagnosis and return to running post SF.  Finally, there is mixed opinion 271 
as to the effect of increased turnover. While increased formation temporarily increases bone 272 
porosity and decreases stiffness, it may also induce microdamage repair following bone stress.19 273 




In this study, a physical therapy examination was not performed as the goal was to gather 276 
physiological factors rather than specific musculoskeletal impairments. Koprelainen et al.21 277 
reported that the risks of recurrent SFs across multiple sites may include a high weekly training 278 
mileage, a leg length difference, a high longitudinal arch of the foot, and forefoot varus in 279 
addition to menstrual dysfunction. Thus, these factors may be important to consider in the 280 
examination of runners clinically along with the measures collected in this study. As the current 281 
study controlled for running distance through matching of subjects, the impact of mileage cannot 282 
be determined. Other factors to consider are impact forces and kinematics, which are not easily 283 
collected clinically. Popp et al.27 reported that women who fractured had less bone strength and 284 
greater impact forces than women without fractures,27 and Becker et al.4 reported different 285 
kinematic patterns between runners with and without navicular SFs. 286 
 287 
CLINICAL SIGNIFICANCE 288 
For female runners ages 20-50 years of age with varying running abilities, it is recommended 289 
that screening of intrinsic and extrinsic risk factors be performed to determine potential risks for 290 
SF. Based on the research of others, these factors include nutritional, hormonal,11 menstrual 291 
irregularities, energy deficiency,22 training intensity, training surfaces, diet, and footwear.11 292 
Testing of aBMD is also recommended based on this study and others,11 especially for those 293 
women who report menstrual changes as intensity/frequency/duration of running increase. While 294 
women with these changes may be at increased risk, DXA is encouraged for all female runners 295 
to better inform them about potential increased risks and educate them on prevention. 296 





In this study, a physical examination was not performed as the goal was to gather physiological 300 
factors rather than specific musculoskeletal impairments. Koprelainen et al.21 reported that the 301 
risks of recurrent SFs across multiple sites may include a high weekly training mileage, a leg 302 
length difference, a high longitudinal arch of the foot, and forefoot varus in addition to menstrual 303 
dysfunction. Thus, these factors may be important to consider in the examination of runners 304 
clinically along with the measures collected in this study. As the current study controlled for 305 
running distance through matching of subjects, the impact of mileage cannot be determined.  306 
 307 
Other study limitations include the small sample size, which could potentially impact the ability 308 
to obtain statistical significance. Matching women based on age and running distance likely 309 
reduced some of the impact of small sample size. The sample was also one of convenience and 310 
thus may not represent the population of female runners as a whole. The women in this study 311 
also spanned a wide age range. But despite this heterogeneity of age, differences were found 312 
between groups. 313 
 314 
CONCLUSION 315 
Based on the results of this study, measurement of aBMD, bone turnover markers, and menstrual 316 
change data during training may be important additions to the clinical examination of female 317 
runners. More research is needed on the role of bone turnover markers in assessing risk of SFs 318 
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Bachelor’s  7 7 
Master’s 6 9 









Hispanic 1 1 
































2 0 1 0.96 
3 11 7  
4 4 4  
5 2 5  
6 2 1  












11-20 6 9  
21-30 6 6  
31-40 4 2  
41-50 1 1  














6-7 0 1  
7-8 6 2  
8-9 2 6  
9-10 7 4  
10-11 4 5  













11-18 6 3  
19-25 2 9  
26-33 5 7  
34-40 3 0  
>40 1 0  









TABLE 3. Menstrual status 459 











9-10 years 1 2 1.0 
11-12 years 9 8  
13-14 years 6 8  













30-35 days 2 1  
36 days or more 1 1  
Irregular 6 4  













1-2 days 1 2  
3-4 days 9 9  
5-6 days 8 4  
7-8 days 0 3  
8 days or more 0 0  
No answer 2 1  














TABLE 4. Blood histological, bone density, and body composition results  472 








Albumin 3.2 - 4.9 g/dL 4.3 ± 0.3 4.4 ± 0.2 0.21 0.40 
Vitamin D 18 - 72 pg/mL 51.0 ± 10.0 51.8 ± 21.6 0.88 0.04 
Calcium 8.5 - 10.3 mg/dL 9.3 ± 0.3 9.3 ± 0.3 0.73 0.11 
Estradiol 12.5 - 498 pg/mL† 76.1 ± 105 50.6 ± 67.0 0.35 0.29 
Testosterone 2-45 ng/dL 18.8 ± 8.2 19.1 ± 7.8 0.90 0.03 




5.0 - 18.8 mcg/L 9.9 ± 2.7 8.3 ± 2.4 0.09 0.61 
N-Telopeptide 6.2 - 19.0 mg/dL 11.8 ± 5.0 11.1 ± 4.9 0.67 0.15 
Spine Bone Mineral 
Density 
N/A‡  gm/cm2 1.0 ± 0.09 1.0 ± 0.11 0.15 0.44 
Hip Bone Mineral 
Density 
N/A‡  gm/cm2 0.9 ± 0.1 1.0 ± 0.1 0.03* 0.19 
Fat percent N/A‡  % 31.2 ± 6.1 31.0 ± 5.0 0.94 0.02 
Body Mass Index 18.5-24.9 kg/m2 22.4 ± 2.8 23.2 ± 2.9 0.36 0.28 
* Significant p-value 473 
†Pre-menopausal, influenced by menstrual cycle phase 474 







Figure Caption 480 
FIGURE 1. Bone turnover for each group. There was a moderate correlation within the stress 481 
fracture group between bone resorption (N-telopeptide) and bone formation (bone specific 482 
alkaline phosphatase) but not within the non-stress fracture group. This finding indicates 483 
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Bone Specific Alkaline Phosphatase
Bone Turnover Non-SF Group
r=.09, p=.71
